NASDAQ · Biotechnology

ORMP (ORMP) Stock

$4.39 +7.86% NASDAQ: ORMP Healthcare

Valuation

MetricValue
Price$4.39
Market Cap$179.67M
P/E Ratio2.85
P/B Ratio0.87
P/S Ratio86.55
EPS (TTM)$1.50
52-Week High$5.17
52-Week Low$1.98
Dividend Yield5.84%

Financials & Margins

MetricValue
ROE32.00%
ROA27.71%
ROCE-7.50%
Gross Margin-750.00%
Operating Margin-750.00%
Net Margin3200.00%
Debt/Equity0.01
Current Ratio7.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$3.0M$1.0M$0$2.0M
Operating Profit$-24.0M$-41.0M$-16.0M$-13.0M$-15.0M
Net Profit$-22.0M$-38.0M$6.0M$-19.0M$64.0M
EPS$-0.78$-0.97$0.14$-0.47$1.50
Op Margin-896.1%-1502.0%-1176.8%—-754.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$128.0M$162.0M$221.0M$155.0M$231.0M
Total Liabilities$11.0M$10.0M$58.0M$10.0M$31.0M
Cash$77.0M$40.0M$9.0M$54.0M$46.0M
Borrowings$1.0M$1.0M$52.0M$0$1.0M

Latest News

Lifeward Enters Securities Purchase Agreement Under Oramed Financing Framework MT Newswires · Jul 7, 2026 Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing GlobeNewswire · Jul 7, 2026 Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet PR Newswire · Jun 25, 2026 ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community Zacks Small Cap Research · Jun 18, 2026 Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes PR Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-29.0M$-10.0M$-8.0M$-9.0M
Investing Cash Flow$-23.0M$30.0M$-73.0M$106.0M$4.0M
Financing Cash Flow$0$0$0$-2.0M$-5.0M
Net Cash Flow$58.0M$-37.0M$-31.0M$45.0M$-8.0M
Free Cash Flow$-22.0M$-29.0M$-11.0M$-8.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-7.24%
Quick Ratio6.45
Interest Coverage—
Return 1Y101.44%
Return 3Y33.67%
Return 5Y-66.21%

Ownership

Insiders Held17.93%
Institutions Held31.65%
Institutions Float Held38.57%
Institutional HolderSharesReport Date
BML Capital Management, LLC3,167,2312026-03-31
Aquamarine Financial (cayman) Ltd2,112,3122026-03-31
Mercer Global Advisors, Inc./ADV1,910,5402026-03-31
Gem Investment Advisors, LLC1,640,0692026-03-31
Murchinson Ltd.1,315,2942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLNNClene Inc. $5.29 -1.86% -1.66 $54.53M 0.00%
CNTB $2.07 -1.67% -2.31 $130.02M 0.00%
CNTX $0.62 +4.47% -6.84 $56.69M 0.00%
COYA $4.00 -6.21% -2.62 $72.84M 0.00%
IFRX $1.84 +6.98% -4.16 $132.91M 0.00%

About ORMP

ORMP is led by CEO Nadav Kidron, employs 13 people, headquartered in US, publicly traded since 2007.

ORMP stock trades at $4.39 with a market capitalization of $179.67M. The stock is valued at a price-to-earnings (P/E) ratio of 2.85, price-to-book of 0.87, price-to-sales of 86.55. Over the past 52 weeks the stock has ranged between $1.98 and $5.17, and currently trades 15.1% below its 52-week high. It pays a dividend yielding 5.84%.

On profitability, ORMP generates a return on equity (ROE) of 32.00% — well above the market average, a sign of a high-quality business, return on capital employed of -7.50%, an operating margin of -750.00%, a net profit margin of 3200.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides